A picture taken on May 11, 2012 in a pha : News Photo

A picture taken on May 11, 2012 in a pha

Credit: 
JOEL SAGET / Staff
A picture taken on May 11, 2012 in a pharmacy in Paris shows a box of antiretroviral drug Truvada. The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee approved Gilead Sciences' Truvada as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse on May 10, 2012. Already approved to treat people infected with HIV, Truvada would be a milestone in the worldwide AIDS epidemic by offering a tablet capable of preventing infection in high-risk individuals. AFP PHOTO /JOEL SAGET (Photo credit should read JOEL SAGET/AFP/GettyImages)
Caption:
A picture taken on May 11, 2012 in a pharmacy in Paris shows a box of antiretroviral drug Truvada. The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee approved Gilead Sciences' Truvada as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse on May 10, 2012. Already approved to treat people infected with HIV, Truvada would be a milestone in the worldwide AIDS epidemic by offering a tablet capable of preventing infection in high-risk individuals. AFP PHOTO /JOEL SAGET (Photo credit should read JOEL SAGET/AFP/GettyImages)
Calculate price
View cart
Date created:
May 11, 2012
Editorial #:
144174732
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office."RESTRICTED TO EDITORIAL USE, NO ARCHIVE"
License type:
Rights-managedRights-managed products are licensed with restrictions on usage, such as limitations on size, placement, duration of use and geographic distribution. You will be asked to submit information concerning your intended use of the product, which will determine the scope of usage rights granted.
Collection:
AFP
Max file size:
6,144 x 4,096 px (85.33 x 56.89 in) - 72 dpi - 13.8 MB
Release info:
Not released.More information
Source:
AFP
Barcode:
AFP
Object name:
Par7072601

Keywords

This image is subject to copyright. Getty Images reserves the right to pursue unauthorized users of this image or clip, and to seek damages for copyright violations. To learn more about copyright and Getty Images’ enforcement program, click here. Availability for this image cannot be guaranteed until time of purchase.
A picture taken on May 11 2012 in a pharmacy in Paris shows a box of... News Photo 144174732Box,France,Healthcare And Medicine,Horizontal,Medicine,Medicine,Paris - France,Pharmacy,Picture,Show,Truvada,antiretroviralPhotographer Collection: AFP 2012 AFPA picture taken on May 11, 2012 in a pharmacy in Paris shows a box of antiretroviral drug Truvada. The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee approved Gilead Sciences' Truvada as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse on May 10, 2012. Already approved to treat people infected with HIV, Truvada would be a milestone in the worldwide AIDS epidemic by offering a tablet capable of preventing infection in high-risk individuals. AFP PHOTO /JOEL SAGET (Photo credit should read JOEL SAGET/AFP/GettyImages)